Funded Tech Companies

Locanabio

Locanabio, operating out of San Diego, received investment capital from GV, UCB S.A. and Invus.

Company Overview

Contact Information

Company Background Information

Overview

We are creating a new class of precision medicines to treat a range of human genetic diseases. Locana's RNA-targeting technology platform allows us to precisely address these mutations on the level of RNA. By targeting RNA, our approach avoids the risk of off-target effects in DNA and is suited to address many diseases linked to dysfunctional processing of RNA.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/15/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

James Burns

        

Chief Scientific Officer

Kathie Bishop

        

Vice President

Adam Fowler

        

VP - Bus. Development

Micah Mackison

        

VP - Human Resources

Holly Winter

        

VP - Regulatory Affairs

Amy Jennings

        

Company Investors

• GV
• UCB S.A.
• Invus
• Leerink Partners
• Temasek Holdings
• Arch Venture Partners
• Vida Ventures (Rajul Jain)
• RA Capital
• Lightstone Ventures
• Acuta Capital

Browse more funded tech companies:

Locana | Location

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary